BLN ELITER CAPSULE
BLN ELITER CAPSULE : Product registered in Malaysia. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.
NPRA, Malaysian pharmaceutical products register, retrieved 27 October 2026.
Ministère de la santé de Malaisie / NPRA, Pharmaceutical Products, CC BY 4.0
- Registration number
- MAL20096102TC
- Type
- Natural product
- Published status
- PRODUCT APPROVED
- Licence holder
- APB STANDARD SDN. BHD.
- Manufacturer
- APB STANDARD SDN. BHD.
- Registration date
- 2025-11-03
- Published validity end
- 2030-11-03
The foreign register category does not determine the regulatory category of the product in France.
French and European references for recognised ingredients
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026.
Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.
Published composition
| Published ingredient | Published text and quantity | Identified nutrient or substance |
|---|---|---|
| Curcuma longa | Curcuma longa[210 mg,500 mg] | Not identified |
| Camellia sinensis | Camellia sinensis[160 mg,500 mg] | Not identified |
| Panax ginseng | Panax ginseng[80 mg] | Not identified |
| Ginkgo biloba | Ginkgo biloba[50 mg,500 mg] | Not identified |
The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.
Original register data
View published fields and their variants
- Active ingredients
- Curcuma longa[210 mg,500 mg],Camellia sinensis[160 mg,500 mg],Panax ginseng[80 mg],Ginkgo biloba[50 mg,500 mg]
- Valid until
- 2030-11-03
- Registration date
- 2025-11-03
- Published description
- NATURAL PRODUCT
- Licence holder
- APB STANDARD SDN. BHD.
- Producer
- APB STANDARD SDN. BHD.
- Published name
- BLN ELITER CAPSULE
- Published reference
- 202002123426T
- Registration number
- MAL20096102TC
- Published status
- PRODUCT APPROVED
Official source
View the official register, number MAL20096102TC
Ministère de la santé de Malaisie / NPRA, Pharmaceutical Products, CC BY 4.0
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.